As an optometrist who specialises in dry eye disease (DED), I am constantly trying to stay on top of the latest research and developments, so it was with great enthusiasm that I embarked on the British Contact Lens Association (BCLA)’s dry eye management and contact lens retention certificate course
What? Me? Causing dry eyes? But how? In addition to treating dry eye disease (DED), many medical professionals, including eyecare providers, may be causing dry eyes. The primary ways we are increasing
In the early days of my clinical career, most products for managing dry eye disease (DED) focused on increasing eye lubrication using a limited range of ingredients. Although artificial tears remain a mainstay of DED management today, there now exists a plethora of products for eyecare practitioners
Scotland, like many places, has experienced a cycle of peaks and troughs in Covid-19 case numbers and corresponding restriction levels. I work as part of a wonderful team at Glasgow Caledonian University which has successfully adapted to these changing circumstances. We have an on-site Vision Centre
As research in dry eye disease continues to take important steps forward, industry partners have stepped up to bring an exciting range of multifunctional devices to market to assist practitioners in efficiently and effectively diagnosing and managing dry eye disease.
Iatrogenic dry eye secondary to intravitreal injections is an increasingly reported health concern, yet there’s a dearth of published scientific literature addressing this problem1. I recently completed a study at the University of Auckland to better understand the factors that contribute to the dev
It is well recognised that tear film lipid layer instability is one of the hallmarks of evaporative dry eye disease (DED), yet most artificial tears are water-based and thus do little to replenish the disrupted lipid layer.
Amniotic membrane (amnion) is the innermost layer of the amniotic sac, which surrounds the baby during pregnancy1. Amniotic membrane has been considered an adjunctive treatment for ocular surface conditions since the 1990s2, historically dependent on a surgical setting because sutures or glue were r
It is well recognised that tear film lipid layer instability is one of the hallmarks of evaporative dry eye disease (DED), yet most artificial tears are water-based and thus do little
The Auckland Dry Eye Epidemiology Study is a large population-based, multi-arm, cross-sectional study based at the Ocular Surface Laboratory (OSL) at the University of Auckland. It aims to characterise modifiable and non-modifiable risk factors of dry eye disease (DED) and address some of the gaps i
The addition of data on novel autoantibodies may improve the accuracy of screening dry eye patients for Sjögren’s syndrome, according to research led by Dr Vatinee Bunya from the Penn Dry Eye and Ocular Surface Center in the US.
More than 150 participants from 37 countries are beginning work on the latest Tear Film and Ocular Surface Society (TFOS) workshop, A Lifestyle Epidemic: Ocular Surface Disease. The workshop will be led by a steering committee comprising executive members, Professors Jennifer Craig (chair, New Zeala
